Clinical trial
AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
NCT02036541 · AqueSys, Inc., Industry · Completed
Key facts
| NCT number | NCT02036541 |
|---|---|
| Title | AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma |
| Official title | A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma |
| Lead sponsor | AqueSys, Inc., Industry |
| Collaborators | Allergan Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Glaucoma, Open Angle |
| Intervention type | Device |
| Interventions | AqueSys XEN 45 Glaucoma Implant |
| Enrollment | 65 |
| Start date | Jan 1, 2013 |
| Primary completion | Feb 1, 2016 |
| Completion | Aug 1, 2016 |
| First posted | Jan 15, 2014 |
| Last update posted | Jun 1, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: